Sebia’s Post

𝐉𝐮𝐧𝐞 𝟐𝟖𝐭𝐡 - 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐍𝐞𝐨𝐧𝐚𝐭𝐚𝐥 𝐒𝐜𝐫𝐞𝐞𝐧𝐢𝐧𝐠 𝐃𝐚𝐲 👶🏻🧬 Over the past 60 years, newborn screening has diagnosed and treated millions of babies with genetic diseases, saving and improving lives. However, less than a third of newborns are screened each year globally. Today, we celebrate the life-changing benefits of early disease detection and the opportunities it offers for timely treatment. 🔎 𝐖𝐡𝐲 𝐢𝐬 𝐧𝐞𝐨𝐧𝐚𝐭𝐚𝐥 𝐬𝐜𝐫𝐞𝐞𝐧𝐢𝐧𝐠 𝐢𝐦𝐩𝐨𝐫𝐭𝐚𝐧𝐭? - Early detection of serious but treatable conditions. - Timely intervention to improve long-term outcomes. - Enhanced quality of life for children and families. At Sebia, we are dedicated to providing accurate diagnostic solutions for genetic diseases⤵️ https://lnkd.in/eDw3Y-mf Together, we can ensure a healthy future for every newborn 👣 Let us continue to support and advocate to ensure that all children have access to newborn screening. #NewbornScreening #INSD #NeonatalScreeningMatters #InternationalNeonatalScreeningDay #Sebia

𝐉𝐮𝐧𝐞 𝟐𝟖𝐭𝐡 - 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐍𝐞𝐨𝐧𝐚𝐭𝐚𝐥 𝐒𝐜𝐫𝐞𝐞𝐧𝐢𝐧𝐠 𝐃𝐚𝐲 👶🏻🧬 Over the past 60 years, newborn screening has diagnosed and treated millions of babies with genetic diseases, saving and improving lives. However, less than a third of newborns are screened each year globally.   Today, we celebrate the life-changing benefits of early disease detection and the opportunities it offers for timely treatment.   🔎 𝐖𝐡𝐲 𝐢𝐬 𝐧𝐞𝐨𝐧𝐚𝐭𝐚𝐥 𝐬𝐜𝐫𝐞𝐞𝐧𝐢𝐧𝐠 𝐢𝐦𝐩𝐨𝐫𝐭𝐚𝐧𝐭?  - Early detection of serious but treatable conditions. - Timely intervention to improve long-term outcomes. - Enhanced quality of life for children and families.   At Sebia, we are dedicated to providing accurate diagnostic solutions for genetic diseases⤵️  https://lnkd.in/eQbYtr6F   Together, we can ensure a healthy future for every newborn 👣 Let us continue to support and advocate to ensure that all children have access to newborn screening.   #NewbornScreening #INSD #NeonatalScreeningMatters #InternationalNeonatalScreeningDay #Sebia

𝐉𝐮𝐧𝐞 𝟐𝟖𝐭𝐡 - 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐍𝐞𝐨𝐧𝐚𝐭𝐚𝐥 𝐒𝐜𝐫𝐞𝐞𝐧𝐢𝐧𝐠 𝐃𝐚𝐲 👶🏻🧬 Over the past 60 years, newborn screening has diagnosed and treated millions of babies with genetic diseases, saving and improving lives. However, less than a third of newborns are screened each year globally. Today, we celebrate the life-changing benefits of early disease detection and the opportunities it offers for timely treatment. 🔎 𝐖𝐡𝐲 𝐢𝐬 𝐧𝐞𝐨𝐧𝐚𝐭𝐚𝐥 𝐬𝐜𝐫𝐞𝐞𝐧𝐢𝐧𝐠 𝐢𝐦𝐩𝐨𝐫𝐭𝐚𝐧𝐭? - Early detection of serious but treatable conditions. - Timely intervention to improve long-term outcomes. - Enhanced quality of life for children and families. At Sebia, we are dedicated to providing accurate diagnostic solutions for genetic diseases⤵️ https://lnkd.in/gju77m-f Together, we can ensure a healthy future for every newborn 👣 Let us continue to support and advocate to ensure that all children have access to newborn screening. #NewbornScreening #INSD #NeonatalScreeningMatters #InternationalNeonatalScreeningDay #Sebia

Imagine a world where even the common cold could be fatal for a newborn. This is the reality for infants with Severe Combined Immunodeficiency (SCID), a genetic condition so severe that it's often referred to as 'bubble boy disease.' It's invisible at birth but can be upsetting without early intervention. Newborn screening serves as our shield against this silent threat, capable of detecting SCID before it's too late and paving the way for life-saving treatments. In the delicate first moments of life, a newborn screening can make all the difference. Learn more about the detection of SCID through Newborn Screening in our latest article: https://lnkd.in/dYbeaRMp #NewbornScreening #EarlyDetection #ProtectOurLittleOnes #FightSCID #SCID #EkSahiShuruat #ANewBeginning Trivitron Healthcare

Today is International Neonatal Screening Day. Newborn screening is critical for the early detection of many genetic diseases, providing accurate diagnoses and ensuring rapid referrals within the first few weeks of life. For patients with Krabbe disease, newborn screening is essential. It significantly reduces the time to access vital treatments, which is crucial for their health outcomes. Thanks to the advocacy efforts of patient families and organizations, more states now include Krabbe disease on their newborn screening panels or have RUSP (recommended uniform screening panel) alignment legislation. Learn more about the importance of neonatal screening here ➡️ https://hubs.li/Q02DHcfM0

🔬 Study on Long COVID-19 Symptoms in Children and Adolescents 🚀 A comprehensive study led by Anna-Lisa Sorg, Selina Becht, Marietta Jenkins, Jakob Armann, Ulrich von Both, M.D., Markus Hufnagel, Fabian Lander, Johannes G Liese, Tim Niehues, Verjans Eva, Martin Wetzke, Silvia Stojanov, Uta Behrends, Christian Drosten, Horst Schroten, Rüdiger von Kries examines the association of SARS-CoV-2 seropositivity with symptoms related to myalgic encephalomyelitis and/or chronic fatigue syndrome (ME/CFS) among children and adolescents in Germany. Key Findings: 31.2% reported clustered ME/CFS symptoms, including 40.0% of SARS-CoV-2-seropositive and 29.6% of seronegative participants. After adjustments, the risk ratio for reporting clustered ME/CFS symptoms decreased significantly. https://ow.ly/Rvns50QgROM #COVID19 #PediatricHealth #MedicalResearch #ChronicFatigue #PublicHealth #HealthcareInnovation #ClinicalStudy

"Cold Anaphylaxis in Children: A Case Series from Italy and an Overview of Relevant Literature. Learn more about this topic at https://buff.ly/45FZmN2. Explore the occurrence of cold-induced anaphylaxis in children through a collection of cases from Italy and a comprehensive review of the existing literature. Discover the symptoms, risk factors, and treatment options associated with this condition. Stay informed and raise awareness about cold anaphylaxis in children. #PediatricHealth #AllergicReactions"

📅 Planning for #WSPID 2023 in Durban November 14-17? Don't miss a diagnosis! Stop by bioMérieux’s booth #04 and come discover our @BIOFIRE Syndromic Molecular Testing solutions for #pediatric infectious diseases. Discover our pediatric diagnostic solutions designed to provide you with fast answers here 👉 https://bddy.me/3u3DEoS Better care for relieved parents. #rapidpcr #pediatricinfections #pioneeringdiagnostics

Invasive Group B Strep (#iGBS) in early infancy associated with higher risk of neurodevelopmental impairment in later life Children with a history of invasive Group B Streptococcus (#GBS) disease face a higher risk of moderate to severe neurodevelopmental impairment (#NDI) later in life compared to non-iGBS children, according to a new study published in The Lancet eClinicalMedicine. Risk of moderate/severe NDI among #iGBS survivors varied by location: 2.9% in India, 3.4% in Kenya, 7.7% in Mozambique, 13.9% in South Africa and 23.1% in Argentina. Frequency of mild neurodevelopmental impairment also varied between the countries included in the study, ranging from 18% in Mozambique to 61% in Argentina. The study highlights the need for freely available standardised developmental assessment tests that can be adapted to context for routine use in both clinical practice and to inform public health policy. Better #detection of #iGBS is also needed to link to better healthcare and education for affected children and comprehensive support for their families, requiring context-specific implementation research. https://lnkd.in/gBcaxUwm

https://lnkd.in/dhwWE7_z MORE STUDIES ARE NEEDED!!! https://lnkd.in/dyU_F9ux Impact The current evidence examining associations between SARS-CoV-2 exposure during the neonatal period and developmental outcomes in infancy is limited by there being few studies with extremely small sample sizes. Based on sparse data there was no consistent association between antenatal or neonatal exposure to SARS-CoV-2 infection and an adverse impact on developmental outcomes below 12 months of age for babies born preterm or at term. This study highlights that larger cohorts with outcomes assessed beyond the first year are needed to determine the potential longer-term impact of SARS-CoV-2 infection exposure on child development.